Stanford Medicine researchers are using artificial intelligence to help identify the underlying biology behind Type 2 diabetes.
SDRC Investigators Michael Snyder and Tracey McLaughlin Harness AI to Predict and Identify Type 2 Diabetes Subtypes Using Simple Glucose Monitors
Previous
Previous
SDRC Investigator Natalie Torok Unveils New Insights on Liver Cancer Risk in Type 2 Diabetes Patients
Next
Next